Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

A Study to Determine the Efficacy and Safety of Deucravacitinib Compared With Placebo in Participants With Active Psoriatic Arthritis (PsA) Who Are Naïve to Biologic Disease Modifying Anti-rheumatic Drugs or Had Previously Received TNFα Inhibitor Treatment

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
اقرأ أكثر حفظ في قائمتي
  • المصدر:
    A Multi-center, Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy and Safety of Deucravacitinib in Participants With Active Psoriatic Arthritis (PsA) Who Are Naïve to Biologic Disease Modifying Anti-rheumatic Drugs or Had Previously Received TNFα Inhibitor Treatment
  • الدخول الالكتروني :
    https://clinicaltrials.gov/ct2/show/NCT04908189
  • معلومة اضافية
    • الدخول الالكتروني :
      https://www.bms.com/researchers-and-partners/clinical-trials-and-research.html
      https://www.bmsstudyconnect.com/content/studyconnect/us/en/clinical-trials/NCT04908189.html